Novo Nordisk profit beats on strength in diabetes, obesity treatments
November 01, 2019 at 02:17 AM EDT
Danish pharmaceutical company Novo Nordisk A/S on Friday posted a forecast-beating third-quarter net profit on strong growth for its diabetes and obesity treatments.
